These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32905449)

  • 1. Bis-indole derived nuclear receptor 4A1 (NR4A1) antagonists inhibit TGFβ-induced invasion of embryonal rhabdomyosarcoma cells.
    Shrestha R; Mohankumar K; Safe S
    Am J Cancer Res; 2020; 10(8):2495-2509. PubMed ID: 32905449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGFβ-Induced Lung Cancer Cell Migration Is NR4A1-Dependent.
    Hedrick E; Mohankumar K; Safe S
    Mol Cancer Res; 2018 Dec; 16(12):1991-2002. PubMed ID: 30072581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Histone Methyltransferase Gene G9A Is Regulated by Nuclear Receptor 4A1 in Alveolar Rhabdomyosarcoma Cells.
    Shrestha R; Mohankumar K; Jin UH; Martin G; Safe S
    Mol Cancer Ther; 2021 Mar; 20(3):612-622. PubMed ID: 33277444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming Growth Factor β/NR4A1-Inducible Breast Cancer Cell Migration and Epithelial-to-Mesenchymal Transition Is p38α (Mitogen-Activated Protein Kinase 14) Dependent.
    Hedrick E; Safe S
    Mol Cell Biol; 2017 Sep; 37(18):. PubMed ID: 28674186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear receptor 4A1 (NR4A1) as a drug target for treating rhabdomyosarcoma (RMS).
    Lacey A; Hedrick E; Li X; Patel K; Doddapaneni R; Singh M; Safe S
    Oncotarget; 2016 May; 7(21):31257-69. PubMed ID: 27144436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of NR4A1 Promotes ROS Accumulation and IL24-Dependent Growth Arrest in Rhabdomyosarcoma.
    Hedrick E; Mohankumar K; Lacey A; Safe S
    Mol Cancer Res; 2019 Nov; 17(11):2221-2232. PubMed ID: 31462501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flavonoids kaempferol and quercetin are nuclear receptor 4A1 (NR4A1, Nur77) ligands and inhibit rhabdomyosarcoma cell and tumor growth.
    Shrestha R; Mohankumar K; Martin G; Hailemariam A; Lee SO; Jin UH; Burghardt R; Safe S
    J Exp Clin Cancer Res; 2021 Dec; 40(1):392. PubMed ID: 34906197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear receptor 4A1 (NR4A1) antagonists target paraspeckle component 1 (PSPC1) in cancer cells.
    Mohankumar K; Shrestha R; Safe S
    Mol Carcinog; 2022 Jan; 61(1):73-84. PubMed ID: 34699643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bis-Indole-Derived Nuclear Receptor 4A1 (NR4A1, Nur77) Ligands as Inhibitors of Endometriosis.
    Mohankumar K; Li X; Sung N; Cho YJ; Han SJ; Safe S
    Endocrinology; 2020 Apr; 161(4):. PubMed ID: 32099996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous targeting of insulin-like growth factor-1 receptor and anaplastic lymphoma kinase in embryonal and alveolar rhabdomyosarcoma: a rational choice.
    van Gaal JC; Roeffen MH; Flucke UE; van der Laak JA; van der Heijden G; de Bont ES; Suurmeijer AJ; Versleijen-Jonkers YM; van der Graaf WT
    Eur J Cancer; 2013 Nov; 49(16):3462-70. PubMed ID: 23867124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potent inhibition of breast cancer by bis-indole-derived nuclear receptor 4A1 (NR4A1) antagonists.
    Hedrick E; Li X; Cheng Y; Lacey A; Mohankumar K; Zarei M; Safe S
    Breast Cancer Res Treat; 2019 Aug; 177(1):29-40. PubMed ID: 31119568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NR4A1 Antagonists Inhibit β1-Integrin-Dependent Breast Cancer Cell Migration.
    Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S
    Mol Cell Biol; 2016 May; 36(9):1383-94. PubMed ID: 26929200
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Zhang L; Martin G; Mohankumar K; Hampton JT; Liu WR; Safe S
    Mol Pharmacol; 2022 Jun; 102(2):80-91. PubMed ID: 35680166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and activity of vascular endothelial growth factor and metalloproteinases in alveolar and embryonal rhabdomyosarcoma cell lines.
    Onisto M; Slongo ML; Gregnanin L; Gastaldi T; Carli M; Rosolen A
    Int J Oncol; 2005 Sep; 27(3):791-8. PubMed ID: 16077930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NR4A1 Ligands as Potent Inhibitors of Breast Cancer Cell and Tumor Growth.
    Karki K; Mohankumar K; Schoeller A; Martin G; Shrestha R; Safe S
    Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34072371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear receptor 4A1 as a drug target for breast cancer chemotherapy.
    Hedrick E; Lee SO; Doddapaneni R; Singh M; Safe S
    Endocr Relat Cancer; 2015 Oct; 22(5):831-40. PubMed ID: 26229035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDK-1/AKT pathway as a novel therapeutic target in rhabdomyosarcoma cells using OSU-03012 compound.
    Cen L; Hsieh FC; Lin HJ; Chen CS; Qualman SJ; Lin J
    Br J Cancer; 2007 Sep; 97(6):785-91. PubMed ID: 17848913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperlongumine is a ligand for the orphan nuclear receptor 4A1 (NR4A1).
    Zhang L; Martin G; Mohankumar K; Wright GA; Mariyam F; Safe S
    Front Pharmacol; 2023; 14():1223153. PubMed ID: 37808182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bis-indole-derived NR4A1 antagonists inhibit colon tumor and splenic growth and T-cell exhaustion.
    Mohankumar K; Wright G; Kumaravel S; Shrestha R; Zhang L; Abdelrahim M; Chapkin RS; Safe S
    Cancer Immunol Immunother; 2023 Dec; 72(12):3985-3999. PubMed ID: 37847301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pannexin 1 inhibits rhabdomyosarcoma progression through a mechanism independent of its canonical channel function.
    Xiang X; Langlois S; St-Pierre ME; Barré JF; Grynspan D; Purgina B; Cowan KN
    Oncogenesis; 2018 Nov; 7(11):89. PubMed ID: 30459312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.